Bi‐Hung Peng

526 total citations
20 papers, 310 citations indexed

About

Bi‐Hung Peng is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, Bi‐Hung Peng has authored 20 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 9 papers in Public Health, Environmental and Occupational Health and 4 papers in Immunology. Recurrent topics in Bi‐Hung Peng's work include Mosquito-borne diseases and control (9 papers), Viral Infections and Vectors (7 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Bi‐Hung Peng is often cited by papers focused on Mosquito-borne diseases and control (9 papers), Viral Infections and Vectors (7 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Bi‐Hung Peng collaborates with scholars based in United States, Saudi Arabia and Taiwan. Bi‐Hung Peng's co-authors include Chien‐Te K. Tseng, Abdullah Algaissi, Rong‐Huay Juang, Hui‐Wen Chen, Leon C. W. Lin, Yuhan Liu, Anurodh Shankar Agrawal, Jung‐Chen Lin, Slobodan Paessler and Yuan‐Chih Chang and has published in prestigious journals such as The Journal of Immunology, Advanced Functional Materials and Journal of Virology.

In The Last Decade

Bi‐Hung Peng

19 papers receiving 306 citations

Peers

Bi‐Hung Peng
Maria T. Arévalo United States
Bo Shu China
Janess Mendoza United States
Supriya Ravichandran United States
Bi‐Hung Peng
Citations per year, relative to Bi‐Hung Peng Bi‐Hung Peng (= 1×) peers Shengfeng Wan

Countries citing papers authored by Bi‐Hung Peng

Since Specialization
Citations

This map shows the geographic impact of Bi‐Hung Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bi‐Hung Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bi‐Hung Peng more than expected).

Fields of papers citing papers by Bi‐Hung Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bi‐Hung Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bi‐Hung Peng. The network helps show where Bi‐Hung Peng may publish in the future.

Co-authorship network of co-authors of Bi‐Hung Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Bi‐Hung Peng. A scholar is included among the top collaborators of Bi‐Hung Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bi‐Hung Peng. Bi‐Hung Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Bi‐Hung, et al.. (2024). Arbovirus infection increases the risk for the development of neurodegenerative disease pathology in the murine model. Brain Behavior & Immunity - Health. 38. 100780–100780. 5 indexed citations
2.
Wang, Binbin, Hongjie Xia, Bi‐Hung Peng, et al.. (2024). Pellino-1, a therapeutic target for control of SARS-CoV-2 infection and disease severity. Antiviral Research. 233. 106059–106059. 1 indexed citations
3.
Singh, Ankita, Awadalkareem Adam, Bi‐Hung Peng, et al.. (2024). A murine model of post-acute neurological sequelae following SARS-CoV-2 variant infection. Frontiers in Immunology. 15. 1384516–1384516. 6 indexed citations
4.
Drelich, Aleksandra, Kempaiah Rayavara, Jason Hsu, et al.. (2024). Characterization of Unique Pathological Features of COVID-Associated Coagulopathy: Studies with AC70 hACE2 Transgenic Mice Highly Permissive to SARS-CoV-2 Infection. PLoS Pathogens. 20(6). e1011777–e1011777. 3 indexed citations
5.
Algaissi, Abdullah, Jr‐Shiuan Lin, Wei‐Ting Chen, et al.. (2023). Subunit vaccines with a saponin-based adjuvant boost humoral and cellular immunity to MERS coronavirus. Vaccine. 41(21). 3337–3346. 8 indexed citations
6.
Manning, John T., Junki Maruyama, Timothy G. Wanninger, et al.. (2023). The roles of XJ13 and XJ44-specific mutations within the Candid #1 GPC in Junin virus attenuation. Frontiers in Immunology. 14. 1172792–1172792. 1 indexed citations
7.
Carter, Brandon, Ge Liu, Yuejin Liang, et al.. (2023). A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta. Frontiers in Immunology. 14. 1135815–1135815. 3 indexed citations
8.
Singh, Ankita, Awadalkareem Adam, Bi‐Hung Peng, et al.. (2023). Oral Supplementation with AHCC®, a Standardized Extract of Cultured Lentinula edodes Mycelia, Enhances Host Resistance against SARS-CoV-2 Infection. Pathogens. 12(4). 554–554. 4 indexed citations
9.
Drelich, Aleksandra, Jason Hsu, Bi‐Hung Peng, et al.. (2023). Protective Efficacy of Novel Engineered Human ACE2-Fc Fusion Protein Against Pan-SARS-CoV-2 Infection In Vitro and in Vivo. Journal of Medicinal Chemistry. 66(24). 16646–16657. 3 indexed citations
10.
Adam, Awadalkareem, Huanle Luo, Binbin Wang, et al.. (2021). Optimized production and immunogenicity of an insect virus-based chikungunya virus candidate vaccine in cell culture and animal models. Emerging Microbes & Infections. 10(1). 305–316. 15 indexed citations
11.
Luo, Huanle, E. Winkelmann, Alan D.T. Barrett, et al.. (2020). MAVS Is Essential for Primary CD4 + T Cell Immunity but Not for Recall T Cell Responses following an Attenuated West Nile Virus Infection. UNC Libraries. 2 indexed citations
12.
Hashem, Anwar M., Abdullah Algaissi, Anurodh Shankar Agrawal, et al.. (2019). CD40-targeted S1 subunit vaccine protects against MERS-CoV and S1-associated pulmonary immunopathology in transgenic human DPP4 mouse model. The Journal of Immunology. 202(1_Supplement). 139.10–139.10.
13.
Lin, Leon C. W., Jung‐Chen Lin, Anurodh Shankar Agrawal, et al.. (2019). Viromimetic STING Agonist‐Loaded Hollow Polymeric Nanoparticles for Safe and Effective Vaccination against Middle East Respiratory Syndrome Coronavirus. Advanced Functional Materials. 29(28). 1807616–1807616. 132 indexed citations
14.
Rodríguez, Rafael Gómez, Ahmed Yassin, Gerald A. Campbell, et al.. (2019). Encephalomyelitis Resulting from Chronic West Nile Virus Infection: A Case Report. 5(2). 2 indexed citations
15.
Xie, Guorui, Huanle Luo, Lan Pang, et al.. (2015). Dysregulation of Toll-Like Receptor 7 Compromises Innate and Adaptive T Cell Responses and Host Resistance to an Attenuated West Nile Virus Infection in Old Mice. Journal of Virology. 90(3). 1333–1344. 26 indexed citations
16.
Peng, Bi‐Hung, Viktoriya Borisevich, Vsevolod L. Popov, et al.. (2013). Production of IL-8, IL-17, IFN-gamma and IP-10 in human astrocytes correlates with alphavirus attenuation. Veterinary Microbiology. 163(3-4). 223–234. 11 indexed citations
17.
Bhavnani, Suresh K., Gowtham Bellala, Bi‐Hung Peng, et al.. (2013). How Cytokines Co-occur across Rickettsioses Patients: From Bipartite Visual Analytics to Mechanistic Inferences of a Cytokine Storm.. PubMed. 2013. 15–9. 5 indexed citations
18.
Jones, Frank R., Elizabeth S. Gabitzsch, Younong Xu, et al.. (2011). Prevention of influenza virus shedding and protection from lethal H1N1 challenge using a consensus 2009 H1N1 HA and NA adenovirus vector vaccine. Vaccine. 29(40). 7020–7026. 21 indexed citations
19.
Seregin, Alexey, Nadezhda E. Yun, Allison Poussard, et al.. (2010). TC83 replicon vectored vaccine provides protection against Junin virus in guinea pigs. Vaccine. 28(30). 4713–4718. 20 indexed citations
20.
Yun, Nadezhda E., Bi‐Hung Peng, Andrea S. Bertke, et al.. (2009). CD4+ T cells provide protection against acute lethal encephalitis caused by Venezuelan equine encephalitis virus. Vaccine. 27(30). 4064–4073. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026